This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions containing the same; and methods of using the same as anticoagulant agents for modulation of the coagulation cascade.
这项发明通常涉及四环
四氢喹啉化合物及其类似物,以及其药用盐形式,这些化合物是选择性抑制
丝氨酸蛋白酶酶,特别是VIIa因子的;含有同样化合物的药物组合物;以及将其用作抗凝剂调节凝血级联的方法。